Alembic Pharmaceuticals
APLLTD.NS
#3925
Rank
C$3.51 B
Marketcap
$17.88
Share price
2.01%
Change (1 day)
43.19%
Change (1 year)

Operating Margin for Alembic Pharmaceuticals (APLLTD.NS)

Operating Margin as of December 2024 (TTM): 12.22%

According to Alembic Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is 12.22%. At the end of 2023 the company had an Operating Margin of 6.45%.

Operating Margin history for Alembic Pharmaceuticals from 2013 to 2024

20162019202210 %15 %20 %25 %30 %35 %companiesmarketcap.com

Operating Margin at the end of each year

Year Operating Margin Change
20236.45%-46.06%
202211.95%-53.9%
202125.93%16.49%
202022.26%13.07%
201919.68%10.38%
201817.83%2.13%
201717.46%-43.37%
201630.83%72.6%
201517.86%4.68%
201417.07%23.48%
201313.82%22.99%
201211.24%26.42%
20118.89%

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.